Inhibition of endothelin A receptor by a novel- selective receptor antagonist enhances morphine-induced analgesia- Possible functional interaction of dimerized endothelin A and mu-opioid receptors
Send a publication request
close

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.




- Categories : General pain , Publications - ID: 1411

Authors
Y Kurodaab,M Nonakab, Y Kamikubo et al


Lab
The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Journal
Biomedicine & Pharmacotherapy

Abstract
The misuse of opioids has led to an epidemic in recent times. The endothelin A receptor (ETAR) has recently attracted attention as a novel therapeutic target to enhance opioid analgesia. We hypothesized that endothelin A receptors may affect pain mechanisms by heterodimerization with mu-opioid receptors. We examined the mechanisms of ETAR-mediated pain and the potential therapeutic effects of an ETAR antagonist, Compound-E, as an agent for analgesia.

BIOSEB Instruments Used:
Rodent pincher - analgesia meter (BIO-RP-M)

Share this content